News: Acorda Therapeutics Inc (ACOR.OQ)
ACOR.OQ on NASDAQ Stock Exchange Global Select Market
37.26USD
4:00pm EDT
37.26USD
4:00pm EDT
Price Change (% chg)
$-0.71 (-1.87%)
$-0.71 (-1.87%)
Prev Close
$37.97
$37.97
Open
$37.97
$37.97
Day's High
$38.40
$38.40
Day's Low
$36.76
$36.76
Volume
187,402
187,402
Avg. Vol
112,590
112,590
52-wk High
$40.87
$40.87
52-wk Low
$21.34
$21.34
Select another date:
Select another date:
- Cramer's 'Mad Money' Recap: The Market's on a Roll
- Acorda Therapeutics Management Discusses Q2 2013 Results - Earnings Call Transcript
- A Closer Look At Acorda's Post Commercial Stage Strategy
- Acorda Therapeutics Is Expanding Its Franchises To Drive Long-Term Growth
- 5 Stocks Poised for Breakouts
- 2 Buys, 1 Sell In This Year's Biotech Surge
Press Releases
- Acorda Therapeutics to Present at Piper Jaffray 24th Annual Healthcare Conference
- Acorda Therapeutics to Present at Lazard Capital Markets 9th Annual Healthcare Conference
- Acorda Therapeutics Reports Third Quarter 2012 Financial Results
- Acorda Therapeutics Receives Silver Awards from Medical Marketing & Media Magazine for AMPYRA.com Consumer Website and AMPYRA Healthcare Professional Print Campaign
- Acorda Therapeutics Moves Third Quarter Financial Results Call to Wednesday, October 31, 2012
- Acorda Therapeutics to Host Conference Call to Discuss Third Quarter 2012 Financial Results on October 30, 2012
- Acorda Therapeutics Announces Hatch-Waxman Extension of AMPYRA® (dalfampridine) Sustained-Release Formulation Patent
- AMPYRA® Two-Year Safety Data Presented at 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
- Acorda Therapeutics Names Jane Wasman President, International
- PetSmart Set to Join the S&P 500; Cabela's to Join the S&P MidCap 400 and Acorda Therapeutics to be Added to the S&P SmallCap 600

